The UK believes it is closing in on a major drug pricing deal with the White House, the Financial Times
- Under the deal, Britain would pay billions of pounds more to buy some medicines in exchange for the US imposing “low to zero” tariffs for UK pharmaceutical exports
- British officials say talks are at an advanced stage: FT
- The ultimate prize would be for zero tariffs for all drugs made in the UK
- The US could push for a tariff of 10%
- “We are quite close,” one London official ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.